← Back to Search

Neuromodulation Device

Wireless Neuromodulation for Chronic Knee Pain

N/A
Recruiting
Research Sponsored by Curonix LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is over 18 years of age;
Subject has been diagnosed with Kellgren-Lawrence Grade II or III knee osteoarthritis, confirmed by X-ray studies conducted in the last year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial is testing if a new treatment for chronic knee pain is effective. The primary endpoint is if the subjects have a 50% decrease in pain after 1 month.

Who is the study for?
Adults over 18 with chronic knee pain from osteoarthritis (Grade II or III), who've tried at least two other treatments like physical therapy or NSAIDs without success. Candidates should have had temporary relief from a nerve injection and be psychologically fit for implant therapies. Exclusions include severe psychiatric disorders, certain medical conditions, morbid obesity, and those with recent knee surgery.Check my eligibility
What is being tested?
The trial is testing wireless neuromodulation to relieve chronic knee pain in osteoarthritis patients. It compares the effects of active stimulation against no stimulation, focusing on significant pain reduction as measured by a visual scale after one month.See study design
What are the potential side effects?
While not explicitly listed, potential side effects may include discomfort at the implant site, possible skin irritation or infection, and reactions to local anesthetics used during the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
My knee osteoarthritis is moderate to severe, confirmed by recent X-rays.
Select...
My knee pain is due to moderate or severe arthritis, confirmed by recent X-rays.
Select...
I am over 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Responder rate
Secondary outcome measures
Global Perceived Effect scales (GPES)
Koos Jr
Mankoski pain scale
+7 more
Other outcome measures
Treadmill

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionalExperimental Treatment1 Intervention
Single arm, active stimulation
Group II: PlaceboPlacebo Group1 Intervention
When receiving sham stimulation, devices will be programmed to not actively deliver electrical stimulation but still deplete battery life to maintain blinding. Subjects will have to recharge batteries similar to receiving active stimulation. Sites will not have access to WaveCrest programmer. Study devices can only be programmed by Stimwave representatives.

Find a Location

Who is running the clinical trial?

Advanced Spine and PainUNKNOWN
Florida Joint Pain InstituteUNKNOWN
Curonix LLCLead Sponsor
6 Previous Clinical Trials
342 Total Patients Enrolled

Media Library

Wireless neuromodulation (Neuromodulation Device) Clinical Trial Eligibility Overview. Trial Name: NCT03877653 — N/A
Osteoarthritis Research Study Groups: Interventional, Placebo
Osteoarthritis Clinical Trial 2023: Wireless neuromodulation Highlights & Side Effects. Trial Name: NCT03877653 — N/A
Wireless neuromodulation (Neuromodulation Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03877653 — N/A
Osteoarthritis Patient Testimony for trial: Trial Name: NCT03877653 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings remaining in this research project?

"Indeed, this research endeavour is currently recruiting volunteers. The details of the trial first appeared on September 1st 2021 and have been modified up until August 9th 2022."

Answered by AI

What is the geographical scope of this experiment?

"Patients seeking enrolment in this clinical trial can do so at the Texas Institute of Pain and Spine (located in Pearland, TX), Holy Cross Hospital Inc. (in Fort Lauderdale, FL) or Comprehensive and Interventional Pain management LLP (in Henderson, NV). Additionally, there are 12 other participating sites across the country."

Answered by AI

How many individuals are being accepted into the investigation?

"This clinical trial necessitates 100 patients that meet the pre-determined qualifications. Participating individuals can visit either Texas Institute of Pain and Spine in Pearland, Texas or Holy Cross Hospital, Inc located in Fort Lauderdale, Florida."

Answered by AI

Who else is applying?

What state do they live in?
New York
California
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
Main Line Spine
Performance pain and sports medicine
Western Clinical Research
Other
How many prior treatments have patients received?
0
1
2
3+

What questions have other patients asked about this trial?

How long does each visit take and what are the entire set of details regarding this?
PatientReceived 1 prior treatment

Why did patients apply to this trial?

pain and nothing works. I’m interested in the study. I believe it could help.
PatientReceived no prior treatments

How responsive is this trial?

Typically responds via
Phone Call
Most responsive sites:
  1. Performance pain and sports medicine: < 24 hours
Average response time
  • < 1 Day
~14 spots leftby Oct 2024